NeoChord
Latest round
- Series D
Last raised
- Apr 2019
Total raised
- $42M
Investors
- 10
About NeoChord
NeoChord, Inc.Founded in 2007, NeoChord, Inc. is based in St. Louis Park, US. The company specializes in innovative medical technology centered around treatment for mitral valve regurgitation.86 mn.NeoChord, Inc. specializes in innovative medical technology focused on the advancement of mitral valve repair through its core product, the NeoChord Artificial Chordae Delivery System (Model DS1000). This system provides a minimally invasive, echo-guided procedure for treating mitral valve regurgitation, restoring normal mitral valve function. The technology allows for the retensioning of artificial chordae tendineae during a beating heart procedure, enhancing procedural control and preserving further treatment options for patients.NeoChord generates revenue through the sale of its medical devices, specifically the NeoChord Artificial Chordae Delivery System and related consultation services, such as NeoChord ConsultConnect and ConnectCARD. The business model involves direct sales to healthcare facilities, allowing surgeons to order the device for surgical procedures. Although specific pricing is not disclosed, transactions typically occur on a per-case basis, aligning with the needs of hospitals and surgical centers.NeoChord, Inc. The company is also targeting expansion in additional European markets and looks to enter new regions where mitral valve repair solutions are needed.
Who invested in NeoChord
10 investors across 4 rounds
See all investors in NeoChord
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NeoChord
Who invested in NeoChord?
NeoChord has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NeoChord raised?
NeoChord has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did NeoChord last raise money?
NeoChord's most recent round on record is a Series D, in Apr 2019.
What does NeoChord do?
NeoChord is a medical devices & equipment company.
Where is NeoChord headquartered?
NeoChord is headquartered in St. Louis Park, US.
Which VCs invest in companies like NeoChord?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at NeoChord's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like NeoChord? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.